Scout | Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is seeking applications for transformative research in cancer biology or oncology using nanotechnology. Projects should focus on overcoming major challenges in these fields by studying how nanomaterials or nanodevices interact with biological systems, either in delivering nanoparticles to target cancer in living organisms or in characterizing diagnostic devi…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $475,000

Funding Amount: $475,000

Dates

Opportunity Released: July 20, 2023

Open for Submission: July 20, 2023

Submission Deadline: May 4, 2026

Application Window Closes: May 4, 2026

Keywords

Cancer nanotechnology

oncology research

nanomaterials

nanodevices

cancer biology

nanoparticle delivery

in vivo studies

diagnostic devices

transformative discoveries

cancer interventions.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers